ReviewThe Malaysian journal of medical sciences : MJMS2025
Voltage-Gated Sodium Channel, as an Ion Channel in Therapeutics: A Bibliometric Analysis of Global Trends (1984-2023).
Review in The Malaysian journal of medical sciences : MJMS, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Voltage-gated sodium channels (VGSCs) play a critical role in generating and propagating electrical signals in excitable cells. To date, the technology has gained much attention for its therapeutic potential in treating various diseases, including cancer. This study provides a comprehensive bibliometric analysis of VGSC research trends over 40 years (1984-2023) using the Scopus database. A total of 3,170 articles were analysed to explore publication productivity, authorship, key research topics, and collaboration patterns. The analysis identified the leading countries according to the number of articles contributed and determined that the USA, China, and Germany were the most productive. In fact, the USA alone accounts for 41.6% of global VGSC research on therapeutics. Additionally, based on the number of published articles, institutions such as Harvard Medical School and the University of Cambridge were found to be at the forefront of this field. Overall, the performed research focused on the therapeutic applications of VGSCs in conditions like atrial fibrillation, chronic pain, cancer, and genetic diseases. The study also highlights a growing interest in VGSC-related research in the past decade as a result of the advancements in molecular techniques such as next-generation sequencing (NGS) and small interfering RNA (siRNA). These findings suggest that VGSCs will remain a central point in therapeutic research for years to come, with a greater interest in international collaboration to drive further progress.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.